Distinct transcriptomic patterns in bicuspid aortic valve aortopathy suggest a unique mechanism of ascending aortic aneurysm progression
This study reveals that bicuspid aortic valve (BAV) and trileaflet aortic valve (TAV) associated aortic aneurysms follow distinct transcriptomic pathways, with BAV aortopathy characterized by extracellular matrix and smooth muscle dysfunction suggesting a unique predisposition to aneurysm development, whereas TAV aneurysms are primarily driven by immune and inflammatory processes.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The human heart is a relentless pump, but the great artery that carries its lifeblood, the aorta, is more than just a sturdy hose. In some people, a congenital defect causes the heart's main valve to have two flaps instead of the usual three. This condition, known as a bicuspid aortic valve, is the most common heart defect people are born with. While the valve itself can cause problems, the real danger often lies in the wall of the aorta just above it. In many of these patients, the aortic wall weakens and slowly swells, forming an aneurysm. If this swelling grows too large, the wall can tear or burst, a catastrophic event that is often fatal. Doctors currently rely on measuring the width of the artery to decide when to operate, but this strategy is imperfect; many dangerous tears happen in arteries that are still smaller than the standard safety limit. Understanding why the aortic wall fails in these patients, and how that failure differs from other causes of aneurysms, is critical for finding better ways to predict and prevent disaster.
A team of researchers at the University of Utah set out to look inside the cells of the aortic wall to find the answer. They collected tissue samples from sixty patients who were undergoing heart surgery. The group included people with the two-flap valve, both those with a swollen aorta and those with a normal-sized one, as well as people with the standard three-flap valve, again with and without a swollen aorta. The researchers used a technique called RNA sequencing to read the genetic instructions being used by the cells in the tissue at the time of surgery. Think of this as reading the active to-do lists of the cells, which reveals what they are building, breaking down, or reacting to, rather than just looking at the static blueprint of their DNA. By comparing these active lists across the different groups, the team could see how the cells in a bicuspid aortic valve patient's artery differ from those in a patient with a normal valve, and how those differences change when an aneurysm forms.
The study revealed that the cells in the aortic walls of people with the two-flap valve are fundamentally different from those with the three-flap valve, even before any swelling occurs. In the non-swollen arteries of the two-flap group, the cells showed signs of struggling to maintain the structural framework that gives the artery its strength and flexibility. Specifically, the cells responsible for building and organizing the elastic fibers and collagen—the materials that act like the steel cables in a suspension bridge—were turning down the production of key structural proteins. This suggests that the aortic wall in these patients is born with a weakness in its construction, a predisposition that makes it prone to failure. In contrast, the non-swollen arteries of people with the standard three-flap valve did not show this same structural deficit.
When the researchers looked at the arteries that had already swollen into aneurysms, they found a fascinating divergence in how the two groups got there. The two-flap patients with aneurysms showed a continued pattern of structural collapse, with their cells failing to maintain the elastic and collagen networks. However, the three-flap patients with aneurysms showed a different story. Their tissue was dominated by signs of inflammation and immune activity. Their cells were reacting as if the artery wall was under attack, with immune cells gathering and inflammatory signals firing, suggesting that their aneurysms are driven by a process of injury and repair gone wrong, rather than a primary failure of the building materials.
Despite these different paths, the study found that once the aneurysm has fully formed, the two types of tissue begin to look remarkably similar. The distinct genetic signatures that separated the two-flap and three-flap patients in the early stages seemed to fade away in the final, swollen state. The researchers suggest that while the two groups start with different weaknesses—one with a flawed structural foundation and the other with a hyper-reactive immune response—they eventually converge on a common, damaged state. This finding implies that the current practice of treating all aneurysms the same way might miss the unique risks associated with the two-flap valve. By understanding that the two-flap valve patients have a unique, intrinsic weakness in their artery walls that exists long before the swelling appears, doctors may eventually be able to identify these high-risk individuals earlier, perhaps before the artery reaches the dangerous size that currently triggers surgery. The study does not offer a new treatment yet, but it provides a clear map of the different biological roads that lead to the same dangerous destination.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.